1. Home
  2. CHH vs BLCO Comparison

CHH vs BLCO Comparison

Compare CHH & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Choice Hotels International Inc.

CHH

Choice Hotels International Inc.

HOLD

Current Price

$115.01

Market Cap

5.1B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$14.93

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHH
BLCO
Founded
1939
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Hotels/Resorts
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.4B
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
CHH
BLCO
Price
$115.01
$14.93
Analyst Decision
Hold
Buy
Analyst Count
11
11
Target Price
$114.30
$18.45
AVG Volume (30 Days)
626.2K
408.0K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
0.98%
N/A
EPS Growth
27.42
N/A
EPS
0.44
N/A
Revenue
$1,596,793,000.00
$5,101,000,000.00
Revenue This Year
$66.74
$8.65
Revenue Next Year
$0.37
$5.59
P/E Ratio
$261.02
N/A
Revenue Growth
0.75
6.47
52 Week Low
$84.04
$11.63
52 Week High
$136.45
$18.92

Technical Indicators

Market Signals
Indicator
CHH
BLCO
Relative Strength Index (RSI) 57.25 37.00
Support Level $102.06 $14.61
Resistance Level $116.89 $15.67
Average True Range (ATR) 4.30 0.39
MACD 0.70 -0.03
Stochastic Oscillator 80.87 19.73

Price Performance

Historical Comparison
CHH
BLCO

About CHH Choice Hotels International Inc.

At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2025.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: